Alternet
November 25, 2024
Republican candidate for the U.S. Senate in Pennsylvania Mehmet Oz attends evening services at Kingdom Empowerment International Ministries on Oct. 2, 2022. - Tom Gralish/The Philadelphia Inquirer/TNS
Dr. Mehmet Oz — who Donald Trump nominated last week to lead the Centers for Medicare and Medicaid Services — holds a "stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the healthcare sector, such as Amazon," according to the Los Angeles Times.
Per the report, the investments — which are regulated by CMS — could be worth "millions of dollars."
The Times also noted that when Dr. Oz was asked whether "he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate," the Trump nominee refused to comment.
"That’s a problem because if Oz is confirmed and he still holds the investments," the Daily Beast reported, "it won’t be clear if he’s making decisions based on what’s best for Medicare and Medicaid patients, or on what’s best for his stock portfolio, critics told the Times."
The Los Angeles Times' full report is available here.
November 25, 2024
Republican candidate for the U.S. Senate in Pennsylvania Mehmet Oz attends evening services at Kingdom Empowerment International Ministries on Oct. 2, 2022. - Tom Gralish/The Philadelphia Inquirer/TNS
Dr. Mehmet Oz — who Donald Trump nominated last week to lead the Centers for Medicare and Medicaid Services — holds a "stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the healthcare sector, such as Amazon," according to the Los Angeles Times.
Per the report, the investments — which are regulated by CMS — could be worth "millions of dollars."
The Times also noted that when Dr. Oz was asked whether "he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate," the Trump nominee refused to comment.
"That’s a problem because if Oz is confirmed and he still holds the investments," the Daily Beast reported, "it won’t be clear if he’s making decisions based on what’s best for Medicare and Medicaid patients, or on what’s best for his stock portfolio, critics told the Times."
The Los Angeles Times' full report is available here.
The Daily Beast's report is here.
No comments:
Post a Comment